Schott Pharma AG KGaA (WBO:1SXP) Short Interest


WBO:1SXP Schott Pharma AG & CO KGaA WBO:1SXP
61 GF Score
Price €17.30
GF Value €27.79
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WBO:1SXP vs ISRG, BDX, MDLN: Short Interest Comparison

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Short Interest distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Short Interest falls into.


WBO:1SXP
61GF Score
Schott Pharma AG & CO KGaA WBO:1SXP
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Schott Pharma AG KGaA (WBO:1SXP) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €17.30 is trading 37.7% below its estimated GF Value™ of €27.79. GuruFocus considers Schott Pharma AG KGaA to be Significantly Undervalued.

Key valuation signals for WBO:1SXP:

  • Short Interest:
  • GF Value™: €27.79 vs. price of €17.30 (37.7% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the WBO:1SXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Schott Pharma AG KGaA Business Description

Other Exchanges 1SXP:Italy1SXP:Germany
Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
61GF Score

Get the complete analysis for WBO:1SXP

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.30
Price
€27.79
GF Value